Navigation Links
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Date:6/8/2009

bmissions with other regulatory agencies globally for the treatment of advanced kidney cancer. Afinitor is being studied in multiple cancer types, including NET, breast, gastric and hepatocellular carcinoma (HCC), as well as tuberous sclerosis complex (TSC) and NHL.

The active ingredient in Afinitor is everolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003. Certican is not approved for use in the US.

Afinitor important safety information

Afinitor is contraindicated in patients with hypersensitivity to everolimus, to other rapamycin derivatives or to any of the excipients. Potentially serious adverse reactions include non-infectious pneumonitis and infections for which patients should be monitored carefully and treated as needed. In addition, non-infectious pneumonitis may require temporary dose reduction and/or interruption or discontinuation. Patients with systemic invasive fungal infections should not receive Afinitor. Oral ulceration is a common side effect with Afinitor. Renal function, blood glucose, lipids and hematological parameters should be evaluated prior to the start of therapy with Afinitor and periodically thereafter. Strong or moderate CYP3A4 or P-glycoprotein inhibitors should be avoided. An increase in the dose of Afinitor is recommended when co-administered with a strong CYP3A4 inducer. Live vaccinations and close contact with those who have received live vaccines should be avoided by patients taking Afinitor. Afinitor should not be used in patients with severe hepatic impairment. Afinitor may cause fetal harm in pregnant women.

The most common adverse reactions irrespective of causality (incidence greater than or equal to 30%) were stomatitis, infections, asthenia, fatigue, cough and diarrhea. The mo
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Research and Markets has ... Consumer Healthcare by Application, Sensor Type & by Geography ... report to their offering. ... increasing momentum for consumer healthcare monitoring and sensing driven ... healthcare will lessen the healthcare cost of the patient ...
(Date:7/23/2014)... 2014 Research and Markets  has announced ... by Product, End-user & by Lead Type - Global ... http://photos.prnewswire.com/prnh/20130307/600769 The ... major segments, namely, holter monitor, resting, and stress type ... $3,683 million in 2013 and is poised to grow ...
(Date:7/23/2014)... July 23, 2014 NOT FOR ... OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO ... OR REGULATIONS OF SUCH JURISDICTION. AbbVie (NYSE: ... on Friday, July 25, 2014, before the market opens. ... conference call at 8 a.m. Central time (9 a.m. Eastern). ...
Breaking Medicine Technology:Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6
... 2011 Reportlinker.com announces that a new market research ... Arthritis Therapy Area Pipeline Report ... Report contains detailed information on the arthritis drug pipeline. ... arthritis drugs by company and by stage as well ...
... YORK, April 14, 2011 Reportlinker.com announces that ... its catalogue: Bone Metastases Therapeutics ... http://www.reportlinker.com/p0479826/Bone-Metastases-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... Forecasts to 2017 Summary ...
Cached Medicine Technology:Reportlinker Adds Arthritis Therapy Area Pipeline Report 2Reportlinker Adds Arthritis Therapy Area Pipeline Report 3Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9
(Date:7/24/2014)... Representatives from the internationally acclaimed ... provide educational and support resources at the Society of ... Colorado Springs. , The Annual Meeting brings together leading ... neurointerventional research centers in the world for ... or at) symposiums, physician meetings, exhibit hall interactions and ...
(Date:7/24/2014)... “To care for him who shall have borne ... inspired quote is attributed to Abraham Lincoln. It is also ... And yet the reality of Lincoln’s words, and admonition to ... service in times of conflict, leaves much to be desired, ... in a battle they never expected to wage: the battle ...
(Date:7/24/2014)... 24, 2014 The Republic of Tea, leading ... CARDAMOM CRÈME BRÛLÉE TEA to celebrate “The Hundred-Foot Journey,” a ... and Juliet Blake. A hundred-foot journey begins in the moment ... into a new realm that is far out of your ... physical distance that materially changes the course of your life ...
(Date:7/24/2014)... 24, 2014 Crawford Technologies today ... in partnership with AIIM, focusing on global trends ... insight of the survey indicated that even though ... correspondence for customer service, legal and regulatory compliance ... organizations save exact facsimiles of these documents. , ...
(Date:7/24/2014)... July 24, 2014 Losing a husband or ... sadness as well as shock, fear, guilt, anger, and numbness ... agonizing and confusing. It may be small comfort to know ... it is in fact the case that grieving is a ... psychologist Dr. Hayley Hirschmann of Morris Psychological ...
Breaking Medicine News(10 mins):Health News:Brain Aneurysm Foundation Provides Key Support to NeuroIntervential Physicians 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 3Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 4Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 5Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 2Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 2Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 4
... of a previously ischemic tissue is associated with ... in many organs including the liver. The injury ... consisting of an early stage started upon reoxygenation ... reactive oxygen species formation during reperfusion induces a ...
... and blood clots are often recommended to stop these ... polyps., However, interruption of these medications can place patients ... led by Shai Friedland at the VA Palo Alto ... polyps without interrupting anticoagulation. Their study will be published ...
... types of reconstruction of gastrointestinal continuity after gastric resection. ... how the geometry and flow conditions affect the gastroduodenal ... be the dominant cause of duodenal suture dehiscence, but ... remain unclear. , A research article to be ...
... MAResearchers at Brandeis, in collaboration with several other institutions ... economic costs of dengue fever, the endemic and epidemic ... problem in tropical and sub-tropical countries. The study, ... Journal of Tropical Hygiene , assessed the direct and ...
... Stressed about Work, Money and the EconomySeven out ... MeasuresWASHINGTON, May 7 Economic pressures are having ... 54, according to a new survey by the ... men are reporting significant stress related to work, ...
... The Board of Directors of Tyco International Ltd. (NYSE: ... 0.23 Swiss Francs (CHF) per share, payable on August 26, ... on July 31, 2009, subject to a required filing with ... share is the second installment of an annual dividend of ...
Cached Medicine News:Health News:A new light on the mechanisms of early stage liver reperfusion injury 2Health News:Dengue fever costs billions in health care, lost productivity and absenteeism 2Health News:APA Poll Finds Economic Stress Taking a Toll on Men 2Health News:APA Poll Finds Economic Stress Taking a Toll on Men 3
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
... Ocelot stackable cage system provides anterior ... or total vertebrectomies from T1 to L5. ... Peek Carbon fiber polymer cages that are ... patient needs. The Peek Carbon fiber reinforced ...
... cage system provides anterior column support for ... from T1 to L5. The system consists ... polymer cages that are stacked to a ... Peek Carbon fiber reinforced polymer material emulates ...
... regeneration scaffold. Its highly ... ensures ideal osteoconductivity, while ... maximizes permeability even after ... most meaningful measure of ...
Medicine Products: